Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: A review of the Japanese literature

Journal of Infection and Chemotherapy

Volumn 20, Issue 3, 2014, Pages 181-185

  Izumikawa, Koichi ^a,b   Izumikawa, Kinichi ^c   Takazono, Takahiro ^a   Kosai, Kosuke ^b   Morinaga, Yoshitomo ^b   Nakamura, Shigeki ^a   Kurihara, Shintaro ^a,b   Imamura, Yoshifumi ^a   Miyazaki, Taiga ^a   Tsukamoto, Misuzu ^b   Yanagihara, Katsunori ^b   Hara, Kohei ^b   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c Izumikawa Hospital   (Japan)

Author keywords

Fulminant pneumonia; Mycoplasma pneumoniae; Steroids

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ANTIMYCOBACTERIAL AGENT; ASPARTATE AMINOTRANSFERASE; AZITHROMYCIN; BETA LACTAM; C REACTIVE PROTEIN; CEPHEM DERIVATIVE; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; METHYLPREDNISOLONE; MINOCYCLINE; PENICILLIN DERIVATIVE; PLASMA PROTEIN; PREDNISOLONE; STEROID; TETRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANTIMICROBIAL THERAPY; ARTERIAL OXYGEN SATURATION; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHMA; BIBLIOGRAPHIC DATABASE; CLINICAL FEATURE; COLLAGEN DISEASE; COMPLEMENT FIXATION; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIABETES MELLITUS; DISEASE COURSE; DRUG ACTIVITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG POTENCY; DYSPNEA; ERYTHROCYTE SEDIMENTATION RATE; FATALITY; FEMALE; FEVER; FULMINANT MYCOPLASMA PNEUMONIAE PNEUMONIA; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPERTROPHIC CARDIOMYOPATHY; HYPOXIA; IMMUNOAFFINITY CHROMATOGRAPHY; INDIRECT HEMAGGLUTININ TEST; JAPAN; JAPANESE (PEOPLE); KLEBSIELLA PNEUMONIAE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; OPEN LUNG BIOPSY; OUTCOME ASSESSMENT; PASSIVE AGGLUTINATION; PREGNANCY; RADIODIAGNOSIS; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK FACTOR; SPINCEREBELLAR DEGENERATION; STEROID THERAPY; STEVENS JOHNSON SYNDROME; TREATMENT RESPONSE; TUBERCULIN TEST; ADOLESCENT; EPIDEMIOLOGY; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, MYCOPLASMA; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; STEROIDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84903688908     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2013.09.009     Document Type: Article

References (15)

1. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995;333: 1618-24.
2. Hammerschlag MR. Mycoplasma pneumoniae infections. Curr Opin Infect Dis 2001;14: 181-6.
3. Ishida T, Hashimoto T, Arita M, Tojo Y, Tachibana H, Jinnai M. A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology. J Infect Chemother 2004;10: 359-63.
4. Saito A, Kohno S, Matsushima T, Watanabe A, Oizumi K, Yamaguchi K, et al. Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan. J Infect Chemother 2006;12: 63-9.
5. Miyashita N, Fukano H, Mouri K, Fukuda M, Yoshida K, Kobashi Y, et al. Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study. J Med Microbiol 2005;54: 395-400.
6. Chan ED, Welsh CH. Fulminant Mycoplasma pneumoniae pneumonia. West J Med 1995;162: 133-42.
7. Miyashita N, Obase Y, Ouchi K, Kawasaki K, Kawai Y, Kobashi Y, et al. Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J Med Microbiol 2007;56: 1625-9.
8. Takiguchi Y, Shikama N, Aotsuka N, Koseki H, Terano T, Hirai A. Fulminant Mycoplasma pneumoniae pneumonia. Intern Med 2001;40: 345-8.
9. Fernald GW, Clyde JWA, Denny FW. Immunology of mycoplasma infection. New York: Plenum Medical Book Co; 1981.
10. Tanaka H, Narita M, Teramoto S, Saikai T, Oashi K, Igarashi T, et al. Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults. Chest 2002;121: 1493-7.
11. Takeuchi O, Kawai T, Mühlradt PF, Morr M, Radolf JD, Zychlinsky A, et al. Discrimination of bacterial lipoproteins by toll-like receptor 6. Int Immunol 2001;13: 933-40.
12. Park SJ, Pai KS, Kim AR, Lee JH, Shin JI, Lee SY. Fulminant and fatal multiple organ failure in a 12-year-old boy with Mycoplasma pneumoniae infection. Allergy Asthma Immunol Res 2012;4: 55-7.
13. Kannan TR, Hardy RD, Coalson JJ, Cavuoti DC, Siegel JD, Cagle M, et al. Fatal outcomes in family transmission of Mycoplasma pneumoniae. Clin Infect Dis 2012;54: 225-31.
14. Blackmore TK, Reznikov M, Gordon DL. Clinical utility of the polymerase chain reaction to diagnose Mycoplasma pneumoniae infection. Pathology 1995;27: 177-81.
15. Dorigo-Zetsma JW, Verkooyen RP, van Helden HP, van der Nat H, van den Bosch JM. Molecular detection of Mycoplasma pneumoniae in adults with community-acquired pneumonia requiring hospitalization. J Clin Microbiol 2001;39: 1184-6.